The glycomics/glycobiology market is projected to reach USD 3.7 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 15.5% during the forecast period. Growth in the glycomics/glycobiology market can be attributed to factors such as the collaborations and partnerships among market players for the development of glycobiology products, advanced technology for glycobiology, increasing prevalence of cancer and increased use of glycans as biomarkers to identify diseases.
The global glycomics/glycobiology market is highly competitive. The prominent players operating in this market include Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan), Bio-Techne (US), Agilent Technologies (US), Sumitomo Bakelite Co. Ltd. (Japan), Bruker Corporation (US), Shimadzu Corporation (Japan), Danaher Corporation (US), AMS Bio (UK), Ludger Ltd (UK), Z Biotech, LLC (US), Chemily Glycoscience (US), CD BioGlyco (US), GlycoDiag (France), Kode Biotech Limited (New Zealand), Glyxera GmBH (Germany), Lectenz Bio (US), Glycomix Ltd (UK), IEC Group (Italy), Asparia Glycomics (Spain) and Ray Biotech Life Inc. (US) . Product launch, partnerships, collaborations and geographic expansion are the key growth strategies undertaken by these companies to maintain their positions in the market.
To know about the assumptions considered for the study download the pdf brochure
Merck KGaA (Germany)
Merck KGaA is also one of the leading players in the glycomics/glycobiology market. The company focuses on inorganic growth strategies such as investment to strengthen its market position. The company invested USD 20.52 Million to build new science laboratory in Switzerland for fostering the experiments and research.
Thermo Fisher Scientific (US)
Thermo Fisher Scientific held the second position in the glycomics/glycobiology market. The company has entered into collaborations and partnerships with a number of life science companies to develop and promote the use of glycobiology products and is recognized for its contribution in the glycobiology space. TransMIT GmBH (Germany) and OwlStone Medical (UK) are some of the major agreement and collaboration partners of the company.
Agilent Technologies (US)
Agilent Technologies provides a comprehensive portfolio of chromatography systems, along with enzymes, kits, and standards in glycomics/glycobiology market. The company has a strong presence in North America and Europe. The company focuses on product launches and partnerships to maintain its position in the market.
Glycomics/Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE